Zyversa Therapeutics Eulerpool naujienos

Zyversa Therapeutics Eulerpool News

Zyversa Therapeutics akcijų naujienos

Zyversa Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Zyversa Therapeutics naujienas mes pateikiame čia.

• rugsėjo 3 d. ·

  Seeking Alpha
  ZyVersa Therapeutics files for mixed shelf offering
• rugsėjo 3 d. ·

  Thefly.com
  ZyVersa Therapeutics files $100M mixed securities shelf
• rugpjūčio 9 d. ·

  Yahoo
  ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
• rugpjūčio 9 d. ·

  InvestorPlace
  ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024
• rugpjūčio 9 d. ·

  Seeking Alpha
  ZyVersa Therapeutics GAAP EPS of -$3.31 beats by $0.44
• rugpjūčio 7 d. ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
• rugpjūčio 7 d. ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on extracellular ASC
• liepos 29 d. ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
• liepos 29 d. ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on inflammasome ASC
• liepos 25 d. ·

  Yahoo
  ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100